Advertisement
Screener

VERACYTE, INC. (VCYT) Net Cash Provided by (Used in) Investing Activities, Continuing Operations

3.4 / 5 stars · 67/98 Roast Me

VERACYTE, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations

VERACYTE, INC. (VCYT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$227.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-01.

Discontinued › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-01

  • VERACYTE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$227.00K.
  • VERACYTE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$607.00K.
  • VERACYTE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$113.00K.
  • VERACYTE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$175.00K.
  • VERACYTE, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$4.21M.
  • VERACYTE, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$6.70M.
  • VERACYTE, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$9.01M.
  • VERACYTE, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$1.28M.
Period endNet Cash Provided by (Used in) Investing Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month
2018-03-31-$227.00K
10-Q · filed 2018-05-01
2017-09-30-$607.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$720.00K
derived: sum of 2 quarters · filed 2017-11-07
-$895.00K
10-Q · filed 2017-11-07
-$1.34M
derived: sum of 4 quarters · filed 2018-05-01
2017-06-30-$113.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31
-$288.00K
10-Q · filed 2017-07-31
-$738.00K
derived: sum of 3 quarters · filed 2018-05-01
-$911.00K
derived: sum of 4 quarters · filed 2018-05-01
2017-03-31-$175.00K
10-Q · filed 2018-05-01
-$625.00K
derived: sum of 2 quarters · filed 2018-05-01
-$798.00K
derived: sum of 3 quarters · filed 2018-05-01
-$1.41M
derived: sum of 4 quarters · filed 2018-05-01
2016-12-31-$450.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$623.00K
derived: sum of 2 quarters · filed 2017-11-07
-$1.24M
derived: sum of 3 quarters · filed 2017-11-07
-$4.21M
10-K · filed 2017-03-01
2016-09-30-$173.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$787.00K
derived: sum of 2 quarters · filed 2017-11-07
-$3.76M
10-Q · filed 2017-11-07
-$7.95M
derived: sum of 4 quarters · filed 2017-11-07
2016-06-30-$614.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31
-$3.59M
10-Q · filed 2017-07-31
-$7.78M
derived: sum of 3 quarters · filed 2017-07-31
-$8.90M
derived: sum of 4 quarters · filed 2017-07-31
2016-03-31-$2.98M
10-Q · filed 2017-05-03
-$7.17M
derived: sum of 2 quarters · filed 2017-05-03
-$8.29M
derived: sum of 3 quarters · filed 2017-05-03
-$9.23M
derived: sum of 4 quarters · filed 2017-05-03
2015-12-31-$4.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$5.31M
derived: sum of 2 quarters · filed 2017-03-01
-$6.26M
derived: sum of 3 quarters · filed 2017-03-01
-$6.70M
10-K · filed 2017-03-01
2015-09-30-$1.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$2.07M
derived: sum of 2 quarters · filed 2016-11-03
-$2.51M
10-Q · filed 2016-11-03
-$3.04M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30-$944.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
-$1.39M
10-Q · filed 2016-08-03
-$1.92M
derived: sum of 3 quarters · filed 2017-03-01
-$9.49M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31-$441.00K
10-Q · filed 2016-05-05
-$974.00K
derived: sum of 2 quarters · filed 2017-03-01
-$8.55M
derived: sum of 3 quarters · filed 2017-03-01
-$9.33M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$533.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$8.11M
derived: sum of 2 quarters · filed 2017-03-01
-$8.89M
derived: sum of 3 quarters · filed 2017-03-01
-$9.01M
10-K · filed 2017-03-01
2014-09-30-$7.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$8.35M
derived: sum of 2 quarters · filed 2015-11-05
-$8.48M
10-Q · filed 2015-11-05
-$8.75M
derived: sum of 4 quarters · filed 2016-03-14
2014-06-30-$780.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
-$904.00K
10-Q · filed 2015-08-13
-$1.18M
derived: sum of 3 quarters · filed 2016-03-14
-$1.29M
derived: sum of 4 quarters · filed 2016-03-14
2014-03-31-$124.00K
10-Q · filed 2015-05-15
-$395.00K
derived: sum of 2 quarters · filed 2016-03-14
-$515.00K
derived: sum of 3 quarters · filed 2016-03-14
-$900.00K
derived: sum of 4 quarters · filed 2016-03-14
2013-12-31-$271.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
-$391.00K
derived: sum of 2 quarters · filed 2016-03-14
-$776.00K
derived: sum of 3 quarters · filed 2016-03-14
-$1.28M
10-K · filed 2016-03-14
2013-09-30-$120.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
-$505.00K
derived: sum of 2 quarters · filed 2014-11-13
-$1.01M
10-Q · filed 2014-11-13
-$1.56M
derived: sum of 4 quarters · filed 2015-03-25
2013-06-30-$385.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
-$891.00K
10-Q · filed 2014-08-14
-$1.44M
derived: sum of 3 quarters · filed 2015-03-25
2013-03-31-$506.00K
10-Q · filed 2014-05-09
-$1.06M
derived: sum of 2 quarters · filed 2015-03-25
2012-12-31-$550.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25
-$1.46M
10-K · filed 2015-03-25
2012-09-30-$912.00K
10-Q · filed 2013-11-25
2011-12-31-$331.00K
10-K · filed 2014-03-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B